Blood test may predict bone disease severity

NCT ID NCT02868645

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether a protein called periostin is higher in the blood of people with fibrous dysplasia, a rare bone disease that can cause pain and fractures. Researchers will take blood samples from 65 patients and compare periostin levels to how many bones are affected and how severe the disease is. The goal is to see if a simple blood test could help doctors understand the disease better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could point toward a simple blood test to gauge how severe a patient's fibrous dysplasia is.

What could go wrong

This is a small, observational study with only 65 participants. It does not test any treatment, so it may not lead to any direct benefit for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE FIBROUS DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibrous dysplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de rhumatologie Pavillon F - Hôpital Edouard Herriot

    Lyon, 69437, France